Premium
Successful treatment with rituximab in a patient with an acquired factor V inhibitor
Author(s) -
Lebrun Agnes,
LeroyMatheron Catherine,
Arlet JeanBenoit,
Bartolucci Pablo,
Michel Marc
Publication year - 2008
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.21056
Subject(s) - rituximab , medicine , immunology , gastroenterology , oncology , lymphoma
Rituximab has already been successfully used to treat immune‐mediated bleeding disorders such as acquired factor VIII inhibitor. We report here a case of severe acquired factor V (FV) inhibitor deficiency due to FV inhibitor which has been dramatically improved after rituximab. Am. J. Hematol., 2008. © 2007 Wiley‐Liss, Inc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom